Pozelimab
Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases[1].
Product Specifications
CAS Number
2096328-94-6
Product Name Alternative
REGN3918
UNSPSC
12352203
Target
Complement System
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pozelimab.html
Purity
99.45
Solubility
10 mM in DMSO
Smiles
[Pozelimab]
Molecular Weight
(144.78 kDa)
References & Citations
[1]Latuszek A, et al. Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5. PLoS One. 2020 May 8;15 (5) :e0231892.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
039373-ML750 100 µL
OR2T6, CT (OR2T6, OR2T6P, OR2T9, Olfactory receptor 2T6, OST703, Olfactory receptor 2T9) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
K3398406 1.0 µg DNA
Ctnnd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
MBS2608933-01 48 Well
Bovine Carcinoembryonic Antigen (CEA) ELISA Kit
Sign In for Pricing
View Details